首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1701082

數位 PCR 市場規模、佔有率及成長分析（按類型、產品、技術、適應症、應用、最終用戶和地區）－2025 年至 2032 年產業預測

Digital PCR Market Size, Share, and Growth Analysis, By Type (Quantitative, Digital), By Product (Consumables & Reagents, Digital PCR Instruments), By Technology, By Indication, By Application, By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年04月02日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年數位 PCR 市場規模價值 83 億美元，預計將從 2024 年的 90.9 億美元成長到 2032 年的 187.8 億美元，預測期內（2025-2032 年）的複合年成長率為 9.5%。

全球數位 PCR（聚合酵素鏈鎖反應）市場正在經歷顯著成長，這受到對精確核酸定量和分析的需求不斷成長的推動。 dPCR 具有獨特的靈敏度和準確性，在研究、疾病診斷和基因檢測中至關重要，可為專業人士提供可靠的結果，以改善患者護理並推動科學進步。推動市場發展的因素包括感染疾病和遺傳疾病的增加、個人化治療的推動以及基因組學研究的進步。但設備成本高、認知度低等問題仍存在。最近值得注意的發展包括用於同時進行目標檢測的多重數位 PCR 檢測的出現以及數位 PCR 與次世代定序儀的整合。此外，新興市場的日益普及和創新產品的推出也推動了市場的成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Bio-Rad Laboratories, Inc.（USA）
Thermo Fisher Scientific Inc.（USA）
QIAGEN NV（Germany/Netherlands）
F. Hoffmann-La Roche AG（Switzerland）
Merck KGaA（Germany）
Danaher Corporation（USA）
Sysmex Corporation（Japan）
JN Medsys Pte. Ltd.（Singapore）
Stilla Technologies SAS（France）
Standard BioTools Inc.（USA）
Fluidigm Corporation（USA）
Avance Biosciences（USA）
Takara Bio Inc.（Japan）
Meridian Bioscience（USA）
Becton, Dickinson and Company（USA）
Abbott Laboratories（USA）
Promega Corporation（USA）
Endress+Hauser Group Services AG（Switzerland）
Biomerieux（France）
Eppendorf AG（Germany）

結論和建議

簡介目錄

Product Code: SQMIG35G2206

Digital PCR Market size was valued at USD 8.3 billion in 2023 and is poised to grow from USD 9.09 billion in 2024 to USD 18.78 billion by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).

The global digital PCR (Polymerase Chain Reaction) market is experiencing significant growth, fueled by the rising demand for precise nucleic acid quantification and analysis. Its unique sensitivity and accuracy make digital PCR vital for research, disease diagnosis, and genetic testing, empowering professionals to achieve reliable results that enhance patient care and facilitate scientific advancements. Key market drivers include the increasing prevalence of infectious diseases and genetic disorders, the push for personalized therapies, and advancements in genomic research. However, challenges such as high instrument costs and limited awareness persist. Noteworthy recent trends include the emergence of multiplex digital PCR assays for simultaneous target detection and the integration of digital PCR with next-generation sequencing. Additionally, the growing adoption in developing regions and innovative product launches are propelling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Digital Pcr market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Digital Pcr Market Segments Analysis

Global Digital PCR Market is segmented by Type, Product, Technology, Indication, Application, End User and region. Based on Type, the market is segmented into Quantitative, Digital and End-point. Based on Product, the market is segmented into Consumables & Reagents, Digital PCR Instruments and Software & Services. Based on Technology, the market is segmented into Droplet Digital PCR, Chip-based Digital PCR and Others. Based on Indication, the market is segmented into Oncology, Infectious Disease, Genetic Disorders and Others. Based on Application, the market is segmented into Clinical Applications, Research Applications, Forensic Applications, Environmental Applications and Other Applications. Based on End User, the market is segmented into Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and CDMOs, Forensic Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Digital Pcr Market

The digital PCR market is significantly driven by the rising demand for precise diagnostic tools within the healthcare sector. As the industry increasingly embraces precision medicine, there is a heightened need for testing methods that offer high sensitivity and specificity. Digital PCR technology plays a crucial role in clinical diagnostics and research by proficiently detecting genetic alterations, cancer biomarkers, and infectious diseases. The emphasis on quality diagnostics is pivotal in customizing therapies tailored to individual patient needs, further fueling the demand for personalized treatment approaches. This growing requirement for superior diagnostic accuracy is propelling substantial growth in the digital PCR market.

Restraints in the Digital Pcr Market

The digital PCR market faces significant challenges primarily due to the high costs associated with essential equipment and consumables, which pose a substantial barrier, especially for smaller laboratories in developing nations. The financial investment required for the necessary apparatus and reagents can deter access to advanced diagnostic technologies. As a result, many healthcare providers might lean towards more affordable traditional PCR methods, hindering the widespread adoption and integration of digital PCR solutions. This financial constraint ultimately limits the market's growth potential, as the disparity in access can stifle innovation and prevent smaller labs from fully embracing the benefits of digital PCR technology.

Market Trends of the Digital Pcr Market

The digital PCR market is currently experiencing a significant trend marked by the integration of machine learning (ML) and artificial intelligence (AI). This advancement enhances data processing capabilities, allowing for more accurate analysis of complex genetic information. AI algorithms streamline workflows by automating routine tasks and refining experimental designs, ultimately boosting productivity. Furthermore, machine learning facilitates improved modeling, leading to deeper insights into genetic variants and the underlying causes of diseases. As a result, there is a growing demand for sophisticated diagnostic tools across various sectors, which is concurrently increasing the usability and appeal of digital PCR devices, positioning the market for robust growth.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis

Global Digital PCR Market Size by Type & CAGR (2025-2032)

Market Overview
Quantitative
Digital
End-point

Global Digital PCR Market Size by Product & CAGR (2025-2032)

Market Overview
Consumables & Reagents
Digital PCR Instruments
Software & Services

Global Digital PCR Market Size by Technology & CAGR (2025-2032)

Market Overview
Droplet Digital PCR
Chip-based Digital PCR
Others

Global Digital PCR Market Size by Indication & CAGR (2025-2032)

Market Overview
Oncology
Infectious Disease
Genetic Disorders
Others

Global Digital PCR Market Size by Application & CAGR (2025-2032)

Market Overview
Clinical Applications
Research Applications
Forensic Applications
Environmental Applications
Other Applications

Global Digital PCR Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals and Diagnostic Laboratories
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
CROs and CDMOs
Forensic Laboratories
Other End Users

Global Digital PCR Market Size & CAGR (2025-2032)

North America (Type, Product, Technology, Indication, Application, End User)
- US
- Canada
Europe (Type, Product, Technology, Indication, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Product, Technology, Indication, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Product, Technology, Indication, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Product, Technology, Indication, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Germany/Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JN Medsys Pte. Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stilla Technologies SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Standard BioTools Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avance Biosciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endress+Hauser Group Services AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eppendorf AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments